IMRX · Immuneering Corp
United States · RS rating 10 · As of 2026-10-14
| Price | 3.42 USD |
|---|---|
| 1-day change | -3.9% |
| RS rating (overall / 1M / 3M / 12M) | 10 / 10 / 13 / 16 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 32 / 16 / 44 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | +52.6% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +58.9% |
| Market cap (USD) | $396.6M |